- Supported exchanges /
- WAR /
- SPH.WAR
Sopharma AD (SPH WAR) stock market data APIs
Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylprednisolon, for severe allergies and life-threatening conditions; Vitamin C; Valeriana, used to reduce the stress; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal cosmetics, including plasters, bandages, and sanitary-hygiene products focused; and prescription medicines, on the counter products, and veterinary products. In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services. Further, it is involved in trading of food supplements; secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
Sopharma AD Financial Data Overview
| 13.95 | |
| 13.95 | |
| - | |
| 13.95 | |
| 13.95 | |
| 11.2486-15.6634 | |
| 2 312 M | |
| 13.8119 | |
| 166 M | |
| 1 974 M | |
| 0.0277 | |
| -0.041 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Sopharma AD Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 974 M
- EBITDA 104 M
- Earnings Per Share 1.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Sopharma AD Earnings via APIs
- Latest Release 2024-10-30
- EPS/Forecast NaN
Get Sopharma AD End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
